NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/ENT/Salivary Gland Tumors
    Salivary Gland Tumors
    easy
    ear ENT

    A 52-year-old man presents with a slow-growing, painless swelling in the region of the parotid gland for 6 months. On examination, the mass is firm, mobile, and does not involve the overlying skin. Histopathology reveals a tumor composed of epithelial and myoepithelial components arranged in a characteristic pattern. What is the most common benign salivary gland tumor?

    A. Oncocytoma
    B. Warthin's tumor
    C. Myoepithelioma
    D. Pleomorphic adenoma

    Explanation

    ## Most Common Benign Salivary Gland Tumor **Key Point:** Pleomorphic adenoma (mixed tumor) is the most common benign salivary gland tumor, accounting for 45–60% of all parotid tumors and 50–80% of all benign salivary gland neoplasms. ### Clinical Features of Pleomorphic Adenoma - **Location:** Parotid gland (80%), submandibular gland (10%), minor salivary glands (10%) - **Presentation:** Slow-growing, painless, mobile mass - **Age:** Typically 40–60 years - **Growth rate:** Very slow; may remain stable for years ### Histopathology - Mixed epithelial and myoepithelial components - Characteristic "Swiss cheese" appearance with myxoid, chondroid, and hyaline stroma - Well-demarcated but NOT encapsulated (pseudo-encapsulated) - **Critical point:** Recurrence risk if incompletely excised due to satellite nodules ### Management - **Treatment:** Surgical excision with superficial or total parotidectomy (depending on location) - **Prognosis:** Excellent; malignant transformation rare (<5% over 20 years) - **Recurrence:** 2–5% if properly excised; up to 45% if enucleated ### Comparison with Other Benign Tumors | Feature | Pleomorphic Adenoma | Warthin's Tumor | Oncocytoma | |---------|-------------------|-----------------|------------| | Frequency | 45–60% of parotid | 5–15% of parotid | 1–2% | | Age | 40–60 years | 50–70 years | 60+ years | | Location | Parotid > submandibular | Parotid (tail) | Parotid | | Gender | Equal | Male >> female | Male >> female | | Growth | Very slow | Slow | Slow | | Malignant potential | <5% | None | None | **High-Yield:** Pleomorphic adenoma is the single most common salivary gland tumor overall — both benign and malignant combined in the parotid gland.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More ENT Questions